Virtual Medicinal Product (VMP) - Dinoprostone 5mg/0.5ml extraamniotic solution ampoules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Dinoprostone 5mg/0.5ml extraamniotic solution ampoules | Start Date 01-05-2012 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Extraamniotic
- Form
- Liquid
- Ontology Form/Route
- solutioninstillation.extraamniotic
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- G02AD02
Code | Start Date | End Date |
---|---|---|
20470911000001107 | 01-05-2012 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Dinoprostone | Based on Ingredient Substance | 10 mg | 1 ml |
Name
Dinoprostone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMDinoprostone
-
VMP(Current) Dinoprostone 5mg/0.5ml extraamniotic...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ampoule |